Sai Life Sciences launches peptide research centre in HyderabadIllustrative image – not actual.

Sai Life Sciences, a contract research, development, and manufacturing organisation (CRDMO), has launched a dedicated Peptide Research Centre at its integrated R&D campus in Hyderabad. This strategic expansion is aimed at supporting the growing demand for complex peptide synthesis and conjugation in the pharmaceutical industry. 

The centre is designed to assist innovator pharma and biotech companies in peptide synthesis, discovery, and advanced modalities, including complex conjugates. Equipped with state-of-the-art automation, advanced liquid handling, robotics, and high-throughput systems, the facility aims to enhance precision, scalability, and efficiency in developing novel peptide-based therapeutics. According to Maneesh Pingle, Head of Discovery Services at Sai Life Sciences, peptide-based therapeutics are in high demand due to their superior specificity, biocompatibility, and reduced risk of off-target effects.

The Peptide Research Centre will be fully integrated with Sai Life Sciences’ end-to-end discovery services, encompassing synthetic and medicinal chemistry, biology, and toxicology, among other disciplines. The approach ensures seamless transitions across different stages of drug discovery, and enhancing success rates.

This expansion reinforces the company’s position as a key partner for global pharmaceutical firms seeking cutting-edge peptide solutions for next-generation drug development.

← All latest storiesBack to top →